TipRanks
Go Ultimate55% OFF

Gilead Sciences (GILD) Income Statement

Gilead Sciences Income Statement

Last quarter (Q3 2026), Gilead Sciences's total revenue was $8.30B, an increase of 6.83% from the same quarter last year. In Q3, Gilead Sciences's net income was $2.43B. See Gilead Sciences’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
$ 29.44B$ 28.75B$ 27.12B$ 27.28B$ 27.30B
$ 23.21B$ 22.50B$ 20.62B$ 21.62B$ 20.70B
$ 11.51B$ 20.84B$ 13.01B$ 14.29B$ 10.79B
Depreciation and Amortization$ 2.76B$ 2.77B$ 2.69B$ 2.10B$ 2.05B
$ 13.58B$ 4.43B$ 10.50B$ 8.85B$ 11.33B
$ 11.70B$ 1.66B$ 7.61B$ 7.33B$ 9.92B
$ -1.91B$ -972.00M$ -746.00M$ -1.52B$ -1.64B
$ 9.80B$ 690.00M$ 6.86B$ 5.81B$ 8.28B
$ 8.51B$ 480.00M$ 5.67B$ 4.59B$ 6.22B
Per Share Metrics
Basic EPS$ 6.84$ 0.38$ 4.54$ 3.66$ 4.96
Diluted EPS$ 6.78$ 0.38$ 4.50$ 3.64$ 4.93
Weighted Average Shares Outstanding1.24B1.25B1.25B1.25B1.26B
Weighted Average Shares Outstanding (Diluted)1.25B1.25B1.26B1.26B1.26B

Currency in USD

Gilead Sciences Earnings and Revenue History

012B24B36B0 %12 %24 %36 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin